European Access Academy
A multi-stakeholder initiative aiming to facilitate and support the development of a joint European value framework for the assessment of innovative health technologies
The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.
The
EAA Faculty is acting as Steering Committee for the EAA's work, providing guidance on strategy, supporting peer-reviewed publications and ensuring scientific integrity. As such, it is listed in the EU Transparency Registry and was accepted as a member of the European Commission's HTA Stakeholder Network.
December 11th, 2025: A Pulse check on EU HTA - Status at the End of Year One
At the EAA Fall Convention at Université Paris Cité we asked participating stakeholders about their opinion whether “EU HTA is on the “Road to Success” to achieve “best outcomes for patients and society as a whole” as stipulated by Recital 3 of the Regulation.
An average rating of 5.3 on a scale from 1 (not at all on the road to success) to 10 (it is successful already) shows that stakeholders generally believe that EU HTA is on the right path but that there is opportunity for improvement. Interestingly, HTAbody and patient representatives suggested the highest average rating – 7.0, while Health Technolgoy Developers gave the lowest average rating – 4.4.
A range of comments further illustrate the evaluation of the implementation of the EU HTA Regulation – a small selection:
This Pulse Check will be the baseline for measurements at upcoming EAA Conventions (e.g., EAA Spring Convention, April 16/17 2026 in Brussels; EAA Fall Convention, November 19/20 2026 in Lisbon) – we’re excited to follow progress and evaluation of the developing EU HTA system.
SAVE the DATE
for the EAA Spring Convention 2026:
April 16/17 in Brussels
jointly hosted by the EAA with
Cancer Patients Europe (CPE)
&
European Hematology Association (EHA)
EAA Fall Convention 2025 'EU HTA - Procedural Insights & First Learnings', jointly hosted by EAA & EURORDIS,
&
the Pre-Convention Meeting 'EU HTA - Approaching Existing Challenges for SMEs', jointly hosted by EAA & EUCOPE,
at Université Paris Cité
NOW AVAILABLE: Video recordings & additional resources
Click HERE to watch & review the sessions
EAA Proceedings Issue #8
THANK YOU to everyone who contributed to the EAA Fall Convention (jointly hosted by EAA & EURORDIS) and the pre-convention meeting (jointly hosted by EAA & EUCOPE)!
We had excellent, heated and fruitful discussions and look forward to reviewing the outcomes and developing the further work agenda.
EAA News & Media Posts - Archive
December 8, 2025: EAA Comment on Risk of Type 2 Error in IQWiG's Assessment of Lecanemab
December 4, 2025: EAA Comment on HTACG Annual Work Programme for 2026
November 27, 2025: Memorial Symposium for Prof. Dr. Friedrich Wilhelm Schwartz, the "father of public health in Germany"
July 1st & 2nd, 2025: DG Santé Events on EU HTA in Brussels
The EAA would like to commend Maya Matthews and DG Santé for organizing exciting days on EU HTA in Brussels.
June 23, 2025: EAA Presentations at API-CCS event in Paris
Download the slides that were presented by the EAA Secretariat:
November 25, 2024: Open Letter from the EAA Faculty to the HTACG and DG Santé on the EU HTA Methods Guidance Documents
November 19, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC for Medical Devices
October 22, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC
June 25, 2024: EAA Faculty Feedback on the Draft Implementing Act on CoI
June 19, 2024: EAA Presentation at HTAi in Sevilla, Spain
April 14, 2024: EAA Faculty Statement on HTA CG Methodological Guideline for Treatment Comparisons
April 2, 2024: EAA Faculty Feedback on the Draft Implementing Act on JCA
Feb 19, 2024: EAA Post: 'Uncertainty - Friend or Foe'
Feb 06, 2024: EAA Post regarding 'Roadblocks' for EU HTA
Jan 15, 2024: EAA Post regarding the EU HTA Implementing Acts
Topical Collection at the Journal of Market Access and Health Policy on EU HTA:
The European Access Academy (EAA) and the Market Access Society (MAS) are editing a Topical Collection at JMAHP focusing on EU HTA, with Jörg Ruof and Mondher Toumi as guest editors. The goal of the Collection is to generate a comprehensive resource consolidating relevant information and diverse perspectives from various stakeholders and a range of focus topics regarding EU HTA.
Access the Collection HERE directly at the journal or find a list of all articles in this collection HERE.
